Loading the session
Loading the session
Loading instrument
$92.18
+0.00%Delayed · Pre-marketDelayed 15 minutes · Source: ViewTrade · 4 Nov 2026, 15:21 IST · A quote does not mean the product is available to trade on your account.
Opens 8:00 pm IST
Opens 8:00 pm IST
Opens 8:00 pm IST
In brief
Questions investors ask
Quotes run fifteen minutes behind.
1 month: +10.7% (SPY −2.6%, XLB +6.2%). 3 months: +14.0% (SPY −2.2%, XLB +1.1%). 1 year: +48.5% (SPY +10.4%, XLB +23.5%). Price change to the 3 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: IFF, SPY and XLB · as of 3 Nov 2026
16.5M shares were sold short at the 15 Oct 2026 settlement, 6.5% of the 255.1M shares outstanding; covering them would take 8.4 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Closed at $92.18 on 3 Nov 2026: 3.2% below the 52-week high of $95.27 (2 Nov 2026) and 49.3% above the low of $61.73 (10 Nov 2025).
Daily price bars, split-adjusted · as of 3 Nov 2026
The 3 Nov 2026 close of $92.18 was 5.7% above its 50-day average ($87.17) and 17.0% above its 200-day average ($78.76). It has closed above the 200-day for 155 sessions, since 25 Mar 2026. The 50-day average crossed above the 200-day on 13 Feb 2026, 181 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 3 Nov 2026
$0.40 a share, payable 13 Jan 2027; unchanged from the previous payment (ex-date 18 Sep 2026).
Corporate actions record · as of 4 Nov 2026
Price return, split-adjusted
At the 3 Nov 2026 close
International Flavors & Fragrances is the largest specialty ingredients producer globally. It sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations and partners with customers to deliver custom solutions. Through its taste and scent segments, which each generate around 25% of profits, IFF is a leading flavor and fragrance producer. The health and biosciences business, which generates 30% of profits, is a global leader in probiotics and enzymes. The remaining profits come from the food ingredients business, which sells texturants, plant-based proteins, and other ingredients, though IFF plans to divest it in a deal expected to close in 2027.
May 6, 2026
+17.18%August 8, 2023
−19.37%February 9, 2023
−18.75%